During the past decade, Norton Cancer Institute, Audubon Hospital Campus conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norton Cancer Institute, Audubon Hospital Campus" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Norton Cancer Institute, Audubon Hospital Campus" are "Advanced Colorectal Cancer" (1 trials), "Gastrointestinal Stromal Tumors" (1 trials), "Metastatic Colon Cancer" (1 trials), "Metastatic Colorectal Cancer" (1 trials) and "Pancreatic Cancer Non-resectable" (1 trials). Many other conditions were trialed in "Norton Cancer Institute, Audubon Hospital Campus" in a lesser frequency.

Most popular intervention types in "Norton Cancer Institute, Audubon Hospital Campus" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "DCC-2618" (1 trials), "DS-8201a 5.4 mg/kg Q3W" (1 trials), "DS-8201a 6.4 mg/kg Q3W" (1 trials), "Fruquintinib" (1 trials) and "Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX" (1 trials). Other intervention names were less common.

The vast majority of trials in "Norton Cancer Institute, Audubon Hospital Campus" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Norton Cancer Institute, Audubon Hospital Campus". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Norton Cancer Institute, Audubon Hospital Campus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Norton Cancer Institute, Audubon Hospital Campus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".